期刊文献+

毒物代谢酶基因多态性与结肠腺癌易感性关联 被引量:5

Relation between genetic polymorphism in xenobiotica metabolizing enzymes and risk of sporadic colorectal adenocarcinoma
原文传递
导出
摘要 目的 探讨谷胱甘肽S 转移酶 (GST)M 1、T1和N 乙酰化转移酶 1(NAT1)基因多态与散发性结肠腺癌 (SCRAC)遗传易感性的关联。方法 应用PCR 限制性片段长度多态性 (RFLP)及多重PCR技术检测GSTM 1、GSTT1和NAT1基因多态性。结果 GSTM1、GSTT1空白基因型在对照组与病例组之间的频率比较 ,差异均无显著性 ,而NAT1 10的频率差异有显著性 (2 7.8%∶4 2 .3% ,P <0 .0 5 )。不同临床特征、老年或非老年SCRAC与对照组GSTM 1空白基因型的频率比较 ,差异均无显著性 ;GSTT1空白基因型在SCRAC远端 (6 6 .2 % ,P <0 .0 5 )、DukesC期 (80 .8% ,P <0 .0 1)及低分化(77.1% ,P <0 .0 1)中的频率均显著高于对照组 (4 7.5 % )。NAT1 10在不同部位SCRAC与对照组之间的频率差异无显著性 ,SCRAC在老年 (5 2 .7% ,P <0 .0 1)、DukesC期 (5 3.8% ,P <0 .0 5 )及中分化(5 4 .2 % ,P <0 .0 1)中的频率均显著高于对照组。结论 GSTT1空白基因型与远端SCRAC易感性有关 ,癌肿多处于DukesC期 ,多呈低分化腺癌 ;NAT1 10与SCRAC的遗传易感性有关 ,癌肿多见于老年患者 ,多处于DukesC期 ,多呈中度分化腺癌。 Objective To analyze the association of genetic polymorphism of Glutathione S transferase (GST) M1, T1 and N acetyltransferase 1(NAT1) with genetic susceptibility to sporadic colorectal adenocarcinoma (SCRAC). Methods All subjects were Han people in Hubei province of China. Using multiple PCR and PCR RFLP, we studied the genetic polymorphism of the GSTM1, GSTT1 and NAT1 genes. Results There were no significant differences of the frequency of GSTM1 and GSTT1 null genotype between controls and SCRAC except for the differences of frequency of NAT1 *10 (27.8%∶42.3%, P <0.05), and there were no significant differences of the frequency of GSTM1 null genotype between controls and proximal or distal SCRAC, different Dukes stages, different differentiated SCRAC and the elder or younger SCRAC respectively. The frequency of GSTT1 null genotype was more common in distal SCRAC (66.2%, P <0.05), among SCRAC in Dukes C stage (80.8%, P < 0.01 ) and in poorly differentiated SCRAC (77.1%, P < 0.01 ) when compared with the controls (47.5%). There were no significant differences of the frequency of NAT1 *10 between proximal or distal SCRAC and controls, but the frequency of NAT1 *10 null genotype was more common in the elder SCRAC(52.7%, P <0.01), among SCRAC in Dukes C stage (53.8%, P < 0.05 ) and in moderately differentiated SCRAC(54.2%, P <0.01) when compared with the controls. Conclusions The GSTT1 null genotype may influence the distal SCRAC, and most tumors are in Dukes C stage and poorly differentiated SCRAC. NAT1 *10 may also increase the risk of SCRAC, especially in the elder, and most tumors are in Dukes C stage and moderately differentiated SCRAC.
出处 《中华消化杂志》 CAS CSCD 北大核心 2003年第9期540-543,共4页 Chinese Journal of Digestion
关键词 毒物代谢酶 基因多态性 结肠腺癌 易感性 Colorectal cancer Glutathione S transferase N acetyltransferase Genetic polymorphism
  • 相关文献

参考文献12

  • 1Rebbeck TA. Molecular epidemiology of the human glutathione Stransferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prey, 1997,6:733-743.
  • 2Hengstler JG, Arand M, Herrero ME, et al. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res, 1998,154:47-85.
  • 3Setiawan VW, Zhang ZF, Yu GP, et al. GSTM1 and GSTT1 null genotypes and the risk of gastric cancer. A case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prey, 2000,9:73-80.
  • 4Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res, 2000,463:247-283.
  • 5Hung CF, Chung JG, Liu SI, et al. Arylamine N-acetyltransferase: a possible promoter in Helicobacter pylori-related gastric carcinogenesis. Zhonghua Yi Xue Za Zhi (Taipei), 1999,62:203-208.
  • 6de Kok TM, van Maanen JM. Evaluation of fecal mutagenieity and colorectal cancer risk. Murat Res, 2000,463:53-101.
  • 7Sawada M, Kamataki T. Genetically engineered eels stably expressing cytochrome P450 and the it application to mutagen assays. Murat Res, 1998,411:19-43.
  • 8Katoh T, Nagata N, Kuroda Y, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTM1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis,1996,17 : 1855-1859.
  • 9Gertig DM, Stampfer M, Haiman C, et al. Glulathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev,1998,7:1001-1005.
  • 10Bell DA, Stephens EA, Castranio T, et al. Polyadenylation polymorphism in the acetyltransferase 1 gene( NAT1 ) increases risk of colorectal cancer. Cancer Res, 1995,55 : 3537-3542.

同被引文献49

  • 1陈坤,舒国通,马新源,郑树.肠息肉与结直肠癌发病关系队列研究[J].中国公共卫生,2004,20(2):168-170. 被引量:15
  • 2农芳,周丽雅,林三仁.白细胞介素1基因多态性与北京地区胃癌的关系[J].中华消化杂志,2004,24(12):707-710. 被引量:5
  • 3陈坤,蒋沁婷,俞维萍,马新源,姚开颜,李其龙,郑树.谷胱甘肽转移酶基因多态、饮食暴露与结直肠癌关系的研究[J].中华消化杂志,2004,24(6):377-379. 被引量:3
  • 4Inoue H, Kiyohara C, Marugame T, et al. Cigarette smoking,CYP1A 1 Msp I and GSTM1 genotypes,and colorectal adenomas.Cancer Res, 2000,60 : 3749-3752.
  • 5Ishibe N, Stampfer M, Hunter DJ, et al. A prospective study of cytochrome P450 1A1 polymorphisms and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prey, 2000,9 : 855-856.
  • 6Cotton SC, Sharp L, Little J, et al. Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol, 151:7 32.
  • 7Houlston RS, Tomlinson IP. Polymorphisms and colorectal tumor risk. Gastroenterology,2001,121:282-301.
  • 8Yoshioka M, Katoh T, Nakano M, et al. Glutathione S-transferase(GST) M1, T1, P1, N-acetyltransferase (NAT) 1 and 2 genetic polymorphisms and susceptibility to colorectal cancer. J UOEH,1999,21 : 133-147.
  • 9Kiss I,Sandor J, Pajkos G, et al. Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2El, and glutathione S transferase M1 enzymes. Anticancer Res, 2000,20 :519-522.
  • 10Bell DA, Stephens EA, Castranio T, et al. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res, 1995,55:3537-3542.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部